Novo Nordisk A/S (B Shares) ADRhedged

Novo Nordisk A/S (B Shares) ADRhedged is a currency-hedged exchange-traded fund designed to provide investors with exposure to the ordinary shares of Novo Nordisk A/S (B Shares) through American Depositary Receipts. The fund primarily focuses on the Danish pharmaceutical company, which is widely associated with diabetes care, obesity treatments, and other prescription medicines. Under normal conditions, it invests at least 95% of its net assets in ADRs linked to Novo Nordisk and uses currency swap contracts to reduce the impact of fluctuations between the U.S. dollar and the Danish krone. The structure is intended to help U.S.-based market participants access the company’s equity performance in a hedged format. As a single-stock ETF, Novo Nordisk A/S (B Shares) ADRhedged serves as a specialized vehicle for targeted exposure to one of the most prominent names in global healthcare and biopharmaceutical markets.